Puma Biotechnology, Inc.
Cash Flow Statement
| Line Item | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | Dec 2020 | Sep 2020 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $9.4M | $-3.4M | $4.1M | $-44.7M | $-5.1M | $16.5M | $-15.0M | $-31.5M |
| Depreciation & Amortization | $2.5M | $2.5M | $3.0M | $2.4M | $2.9M | $3.0M | $2.9M | $2.9M |
| Depreciation | $100.0K | $200.0K | $100.0K | $200.0K | $200.0K | $200.0K | $200.0K | $200.0K |
| Amortization | $2.0M | $2.0M | $2.0M | $2.0M | $2.0M | $2.0M | $2.0M | $2.0M |
| Stock-Based Compensation | $3.2M | $3.1M | $4.3M | $4.3M | $18.2M | $5.9M | $9.5M | $7.6M |
| Net Cash from Operating Activities | $-13.9M | $-26.9M | $-5.4M | $10.5M | $-74.0K | $15.7M | $-5.6M | $1.7M |
| Investing Activities | ||||||||
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $2.0M | $9.0M | $4.6M | $-4.5M | $-5.7M | $-5.3M | $10.8M | $-2.6M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $0 | $9.8M | $-2.0K | $-31.9M | $0 | $0 | — | — |
| Net Change in Cash | $-11.9M | $-8.1M | $-816.0K | $-25.9M | $-5.8M | $10.4M | $-4.8M | $-815.0K |
| Free Cash Flow | — | — | — | — | — | — | — | — |